KaloBios Raises $20M
Palo Alto-based Kalobios Pharmaceuticals said Monday that the firm has raised $20M in a Series C venture round. The firm, which is developing therapeutic antibodies, said that the round was led by Lehman Brothers. Other investors include previous investors MPM Capital, Sofinnova Ventures, Alloy Ventures, 5AM Ventures, Singapore Bioinnovations Pte., and Lotus BioScience Ventures. The firm said that the financing will go towards advancing clinical development of the firm's two therapeutic candidates.
posted on Monday, July 23, 2007 (Link to more information)
Related companies:
KaloBios
Related stories:
> KaloBios Pharmaceuticals Files For IPO
> KaloBios Pharmaceuticals Raises $12M
> KaloBios Gets $20m for Clinical Trials
> Artimi Raises $26.5M
> Barosense Raises $27.4M
silicontap.com Home